NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
批准号:
8478085
负责人:
RONG MA
金额:
$27.05万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-15 至 2015-04-30
关键词:
AddressAgonistAnimal ModelApplications GrantsAreaBlood VesselsCell Culture TechniquesCell surfaceCharacteristicsClinical TreatmentComplications of Diabetes MellitusDevelopmentDiabetes MellitusDiabetic NephropathyDown-RegulationDrug DesignEnzymesExtracellular MatrixFamilyFocal Segmental GlomerulosclerosisGenerationsGenesGenetic TranscriptionGlomerular CapillaryGlomerular Filtration RateGlomerular Mesangial CellGlucoseHomologous GeneHumanHyperglycemiaHypertrophyImpairmentIn VitroKidneyKidney DiseasesLinkMeasuresMediatingMessenger RNAMolecularNADPNADPH OxidaseOxidative StressPathway interactionsPhagocytesPhenotypePhysiologicalPlayPropertyProtein IsoformsProteinsRattusReactive Oxygen SpeciesRegulationReportingRestRoleSeriesSignal PathwaySignal TransductionSmooth Muscle MyocytesSourceStagingStreptozocinSurfaceSystemTestingVascular Smooth MuscleVasoconstrictor AgentsWorkarteriolecell typediabeticdiabetic rathemodynamicsin vivointerestkidney cortexmRNA Expressionmembermesangial cellnovelpodocyteprotein expressionreceptorresponse
中文摘要
项目摘要
在糖尿病的早期阶段,GFR变得异常。这种早期血流动力学表型
会导致糖尿病肾病的死亡糖尿病超滤是由
肾传入小动脉和MC对血管收缩剂的反应性降低。还原Ca 2 +
内流是糖尿病中MC收缩力低下的关键因素。然而,底层
机制仍然知之甚少。此外,新出现的证据表明NADPH氧化酶,
特别是Nox 4衍生的ROS在糖尿病肾病的发展中的作用。然而,底层
机制和下游信号通路在很大程度上是未知的。这项建议旨在测试
TRPC 6蛋白是一种新发现的钙通道蛋白,
MCs的功能和通过NADPH氧化酶介导的ROS下调MCs中的蛋白质导致
糖尿病高滤过将测试三个具体目标。(1)确定TRPC 6是否调节收缩
体外、离体和体内系统中肾小球MCs的功能和Ca 2+信号传导。(2)探索假设
ROS介导糖尿病大鼠肾小球系膜细胞TRPC 6蛋白表达下调
(培养的MC)和体内动物模型。(3)确定ROS的来源,重点是NADPH氧化酶,
在TRPC 6下调的信号通路中,ROS下游分子,集中在NF-B上,
糖尿病从这项新研究中获得的信息将促进我们目前对
糖尿病肾病的发生发展的分子机制,并因此提供了一个理论基础,
设计和临床治疗糖尿病的干预提出的途径。此外,TRPC 6还
发现在多种细胞类型中发挥重要作用。然而,TRPC 6通道的调节,特别是在
基因转录水平,目前尚不清楚。拟议的研究将通过以下方式处理这一重要问题:
研究ROS是否通过NF-B机制抑制TRPC 6基因转录。因此,该项目是
对ROS和TRPC 6领域都感兴趣。
英文摘要
Project Summary
At the early stage of diabetes, the GFR becomes supernormal. This early hemodynamic phenotype
provokes the subsequent demise of a diabetic kidney. The diabetic hyperfiltration is derived from a combined
decreased responsiveness of both the renal afferent arterioles and the MCs to vasoconstrictors. Reduced Ca2+
influx is a critical contributing factor to the hypocontractility of MCs in diabetes. However, the underlying
mechanism(s) are still poorly understood. Furthermore, emerging evidence implicates NADPH oxidases-,
particularly Nox4-derived ROS in the development of diabetic nephropathy. However, the underlying
mechanism and downstream signaling pathway are at a large extent unknown. This proposal seeks to test the
hypothesis that TRPC6 protein, a newly found Ca2+ permeable channel protein, contributes to the contractile
function of MCs and downregulation of the protein in MCs by NADPH oxidases-mediated ROS results in
diabetic hyperfiltration. Three specific aims will be tested. (1) Determine whether TRPC6 regulates contractile
function and Ca2+ signaling of glomerular MCs in in vitro, ex vivo, and in vivo systems. (2) Explore the postulate
that ROS mediate downregulation of TRPC6 protein expression in glomerular MCs by diabetes in an in vitro
(cultured MCs) and in vivo animal model. (3) Determine the source of ROS, focusing on NADPH oxidases, and
the molecules downstream ROS, focusing on NF-¿B, in the signaling pathway of TRPC6 downregulation by
diabetes. The information obtained from this novel study will advance our current understanding of the
molecular mechanism for the development of diabetic nephropathy, and therefore provides a rationale for drug
design and clinical treatment of diabetes by intervening in the proposed pathway. In addition, TRPC6 has been
found to play an important role in a variety of cell types. However, regulation of TRPC6 channel, particularly at
gene transcriptional level, is unknown currently. The proposed studies will tackle this important issue by
investigating if ROS repress TRPC6 gene transcription through the NF-¿B mechanism. Thus, this project is of
interest to both ROS and TRPC6 fields.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Store-operated Ca2+ signaling in kidney glomerular mesangial cells
-
批准号:10066344
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2017
-
负责人:RONG MA
-
依托单位:
NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
-
批准号:8291905
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2009
-
负责人:RONG MA
-
依托单位:
NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
-
批准号:7653146
-
项目类别:
-
资助金额:$32.65万
-
财政年份:2009
-
负责人:RONG MA
-
依托单位:
NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
-
批准号:8581827
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:RONG MA
-
依托单位:
NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
-
批准号:7845002
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2009
-
负责人:RONG MA
-
依托单位:
NADPH oxidases-derived ROS downregulate TRPC6 in mesangial cells in diabetes
-
批准号:8069863
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2009
-
负责人:RONG MA
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: